NeoGenomics Inc (NEO)
15.39
+0.03
(+0.20%)
USD |
NASDAQ |
Nov 21, 16:00
15.38
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Total Liabilities (Quarterly): 732.90M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 732.90M |
| June 30, 2024 | 727.39M |
| March 31, 2024 | 716.93M |
| December 31, 2023 | 739.69M |
| September 30, 2023 | 730.81M |
| June 30, 2023 | 738.92M |
| March 31, 2023 | 734.71M |
| December 31, 2022 | 742.01M |
| September 30, 2022 | 742.59M |
| June 30, 2022 | 748.59M |
| March 31, 2022 | 754.54M |
| December 31, 2021 | 761.50M |
| September 30, 2021 | 769.14M |
| June 30, 2021 | 747.95M |
| March 31, 2021 | 650.70M |
| December 31, 2020 | 294.04M |
| September 30, 2020 | 293.06M |
| June 30, 2020 | 291.26M |
| March 31, 2020 | 227.20M |
| December 31, 2019 | 202.10M |
| September 30, 2019 | 214.15M |
| June 30, 2019 | 206.93M |
| March 31, 2019 | 209.50M |
| December 31, 2018 | 184.57M |
| September 30, 2018 | 151.58M |
| Date | Value |
|---|---|
| June 30, 2018 | 181.57M |
| March 31, 2018 | 141.26M |
| December 31, 2017 | 139.88M |
| September 30, 2017 | 144.24M |
| June 30, 2017 | 143.31M |
| March 31, 2017 | 149.61M |
| December 31, 2016 | 150.52M |
| September 30, 2016 | 109.34M |
| June 30, 2016 | 108.19M |
| March 31, 2016 | 106.67M |
| December 31, 2015 | 113.18M |
| September 30, 2015 | 21.89M |
| June 30, 2015 | 22.10M |
| March 31, 2015 | 21.00M |
| December 31, 2014 | 20.70M |
| September 30, 2014 | 19.76M |
| June 30, 2014 | 20.50M |
| March 31, 2014 | 19.82M |
| December 31, 2013 | 18.20M |
| September 30, 2013 | 14.90M |
| June 30, 2013 | 15.02M |
| March 31, 2013 | 14.79M |
| December 31, 2012 | 20.86M |
| September 30, 2012 | 20.08M |
| June 30, 2012 | 18.28M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
202.10M
Minimum
Dec 2019
769.14M
Maximum
Sep 2021
617.30M
Average
733.81M
Median
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp | 4.270B |
| Henry Schein Inc | 5.634B |
| Karyopharm Therapeutics Inc | 349.12M |
| Apellis Pharmaceuticals Inc | 664.74M |
| Beam Therapeutics Inc | 380.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.641B |
| Shareholders Equity (Quarterly) | 908.21M |
| Debt to Equity Ratio | 0.595 |
| Current Ratio | 1.991 |
| Net Debt Paydown Yield | -0.04% |